Ken Griffin Nephros Inc Transaction History

Citadel Advisors LLC

  • $509 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$0.97 - $1.35 $2,953 - $4,110
-3,045 Reduced 16.6%
15,295 $16,000
Q4 2022

Feb 14, 2023
BUY
$0.99 - $1.25 $5,172 - $6,531
5,225 Added 39.84%
18,340 $21,000
Q3 2022

Nov 14, 2022
BUY
$0.97 - $1.87 $962 - $1,855
992 Added 8.18%
13,115 $12,000

Others Institutions Holding NEPH

# of Institutions
19
Shares Held
4.26M
Call Options Held
0
Put Options Held
0
View Full List

About NEPHROS INC

NEPH Quotes by TradingView
  • Ticker NEPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 10,318,800
  • Market Cap $21.3M
  • Description
  • Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water ...
More about NEPH
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email